Navigation Links
Chiltern Wins Multiple Pharma Awards at the Prestigious Annual PharmaTimes Awards Ceremony
Date:1/17/2011

LONDON, Jan. 17, 2011 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Chiltern has won multiple awards at the PharmaTimes Annual Awards 2010 ceremony held at the Park Plaza Riverbank Hotel in London. The competition, established in 1999, celebrates the competence and ability of top clinical research professionals.

Glenn Kerkhof, Chiltern CEO, congratulates all of Chiltern's Award Winners and Finalists. "I am very proud of every Chiltern colleague nominated for an award. They put their best forward each and every day for our clients and their dedication to being the best is evident in all they do. These achievements of the award winners reflect Chiltern's commitment to deliver expert, high quality services around the world and I couldn't be happier that they have received the recognition that is so well-deserved."

Chiltern Award WinnersClinical Research Associate of the Year Gold Award: Helen Chester, Chiltern Resourcing Solutions CRA outsourced to Roche

Clinical Research Associate of the Year Silver Award: Dawn Skingle, Sr. Clinical Research Associate

Clinical Research Team of the Year Bronze Award: Daniel Lowman, Sr. Clinical Research Associate, Kate Backhouse, Clinical Research Associate 2, Jonathan Kinnell, Sr. Manager, Clinical Monitoring, Mark Williams, Clinical Trainer, Europe

Company profileAbout Chiltern:Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries, has 24 offices and legal entities within 20 countries, resources in 37 countries and employs nearly 1,400 people globally. Chiltern provides Early Phase, Global Clinical Development, Late
'/>"/>

SOURCE Chiltern
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Caliper and Seegene Partner to Provide Innovative Multiplex Molecular Diagnostics Products
2. Cell Biosciences Launches New Platform for Multiplex Western Blot Detection
3. European Neurologists Expect Significant Increases in the Use of Both Tysabri and Extavia in Their Multiple Sclerosis Patients the Next Six Months, According to a Recent Report From BioTrends
4. Physiotherapy Associates Announces New Multiple Sclerosis Specialty Treatment Program
5. Sales of Revlimid and the Launch of Several Premium-Priced Emerging Therapies Will Drive Robust 7.2 Percent Annual Growth in the Multiple Myeloma Drug Market
6. Cylene Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hematology Meeting
7. Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma
8. Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients
9. 34-Year-Old Alabama Woman Crosses the Finish Line to Join Team COPAXONE® and Raise Awareness about Multiple Sclerosis
10. New Peripheral Vascular Device Market Research Data Covering Multiple Geographies Released by Millennium Research Group
11. New Trauma Market Research Data Covering Multiple Geographies Released by Millennium Research Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013  Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: ... based on intellectual property developed and owned by ... foremost medical research center, today announced that its ... funding from the Israeli Ministry of Industry and ... support product development and advance clinical trials. Cell ...
(Date:5/23/2013)... , May 23, 2013  Every day, their baby stopped ... to his lungs. April and Bryan Gionfriddo ... weren,t true. "Quite a few doctors said he ... says April Gionfriddo , about her now ... that would work, we would take it and run with ...
(Date:5/23/2013)... May 23, 2013   Direct to implant, ... is an appropriate option for many women with ... reduce their breast cancer risk, or with breast ... process and a second surgery to insert permanent ... same surgery as mastectomy can be a medically ...
Breaking Medicine Technology:Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3
... ViroPharma Incorporated (Nasdaq: VPHM ) ... has granted ViroPharma an exclusive worldwide license to ... delivery platform using Halozyme,s recombinant human hyaluronidase enzyme ... inhibitor. Additionally, Halozyme has agreed not to grant to ...
... Henry Schein, Inc. (NASDAQ: HSIC ), the ... dental, medical and veterinary practitioners, has been ranked number 317 ... Largest Corporations.  Henry Schein,s net sales reached a record $7.5 ... 500 rankings over the past three years, having been ranked ...
Cached Medicine Technology:ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 2ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 3ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 4ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 5ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 6ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 7Henry Schein Ranks #317 in 2011 Fortune 500 Ranking of America's Largest Corporations 2
(Date:5/25/2013)... May 25, 2013 Life science and ... used to detect and create a new substance with ... and are also known as biotechnology reagents. Such reagents ... and education. , This market is driven by factors ... the field of therapeutics, growth in research and rapid ...
(Date:5/25/2013)... York (PRWEB) May 25, 2013 ... litigation underway in U.S. District Court, Western District of ... According to a Case Management Order issued on ... the filing of contested motions in the Actos bladder ... motions. (In re: Actos Product Liability Litigation, MDL No. ...
(Date:5/25/2013)... The report “Global Food Encapsulation Market (2012 ... Shell Materials, Packaging, & Geography: Trends & Forecasts” ... with analysis and forecasting of the global revenue ... and restraining factors for the global food encapsulation ... The market is segmented and revenue are forecasted ...
(Date:5/25/2013)... 25, 2013 Providing patients with their best ... team of weight management professionals. But, aside from educating patients ... Diet Doc’s hCG diets also provide patients, who ... childhood like bullying, more control over their lives by achieving ... with the underlying factors of weight gain derived from earlier ...
(Date:5/25/2013)... York, New York (PRWEB) May 25, 2013 ... who allegedly suffered serious, life-threatening episodes of internal bleeding while ... litigation underway in U.S. District Court, Southern District of Illinois, ... the Court’s website, 818 Pradaxa side effect claims had ... 2013. That’s up from 705 claims reported by the ...
Breaking Medicine News(10 mins):Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3
... the survival rate of children with sarcoma in ... disease sooner, train cancer pathologists, expand radiation therapy ... and other actions, according to an international study ... findings will be presented at the 42nd Congress ...
... Mo. -- For some women, the effects of breast cancer, ... they leave the hospital. Now, researchers in the University of ... breast cancer patients following chemotherapy and found that their environments ... lives. "A lot of times people get mentally ...
... Elsevier / MC Strategies, a pioneer in providing ... partnered with the Association of periOperative Registered Nurses (AORN) ... Perioperative Collection, the only perioperative-specific set of nursing skills ... Standards and Recommended Practices. Authored ...
... HealthDay Reporter , TUESDAY, Oct. 19 (HealthDay News) -- ... risk of breast cancer, new research finds, but it also ups ... a woman,s chances of dying. A study appearing in the ... Association is at odds with previous observational studies that had ...
... beam therapy is safe and effective and may be ... non-small cell lung cancer (NSCLC) patients, according to a ... Journal of Radiation OncologyBiologyPhysics, the official journal of ... is the number one cause of cancer death for ...
... (HealthDay News) -- Newborn hearing screening leads to better ... problems, new European research finds. In a study ... the Netherlands -- more than 570,000 -- researchers identified ... hearing disorders. They then analyzed the social development, gross ...
Cached Medicine News:Health News:Study identifies barriers to successful treatment of children with sarcoma in low-income countries 2Health News:Women fight the effects of chemotherapy long after treatment ends 2Health News:Elsevier/MC Strategies and AORN launch perioperative nursing skills collection 2Health News:Study Shows HRT Even Riskier Than Thought 2Health News:Study Shows HRT Even Riskier Than Thought 3Health News:Proton therapy safe, effective for early-stage lung cancer patients 2Health News:Newborn Hearing Tests More Effective Than Later Screening 2
Features four-way apron closure for super adjustability to fit staff of all shapes and sizes. Top left and right shoulder closures allow adjustment of armhole size and chest area of apron for close a...
Freedom of movement - plus full circle, maximum radiation protection. No other full circle radiation protection design approaches the level of comfort of the VestSkirt, which divides weight between t...
Use this workhorse apron where 360 of protection from direct and scatter radiation is required....
Bio-Rad's Genetic Systems™ HBsAg EIA 3.0 screening and confirmatory assays offer outstanding sensitivity and early detection of HBV infection, helping to meet your testing criteria....
Medicine Products: